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Using a double conjugation method, we developed a probe with high AβO-specific antibody and magnetic nanoparticle conjugation 
efficiency. This probe was successfully used in mouse and rabbit models to detect the presence of toxic AβOs in Alzheimer’s disease and 
image AβO clusters in MRI imaging. 
Abstract
Aβ Oligomers (called AβOs) are small peptides that show early build-up 
in immunohistochemistry and immunochemistry studies, and appear 
before plaques in Alzheimer’s development. High levels of AβOs cause 
loss of memory performance and other 
pathological changes.Early presentation 
of AβOs makes them ideal for diagnostic
targeting with AβO-specific antibodies 
Bound to magnetic nanostructures (MNSs) 
for MRI visibility. Further testing can 
determine effectiveness of future
pharmaceuticals for AD therapy.  
Introduction
MRI Probe Conjugation: The materials required for this are MNS (magnetic 
nanostructures), ACUMNS Antibody, Coupling Buffer, and Activation buffer. First, the 
MNS is bound to ACU193 using coupling buffer and activation buffer, which causes 
S-NHS to bind the receptors on the two entities. Once the conjugation is complete we 
use the BCA Assay to check the percent conjugation on the ACUMNS.  
BCA Assay: This simple method that uses the supernatants from ACU193 containing 
unbound antibody and passes them through an absorbance machine at 562 nm to 
indicate how much antibody was not bound to the MNS. 
Immunohistology on Mouse and Rabbits Brain Slices: In this process, a secondary 
antibody is bound to an immunofluorescence tag which indicates the presence of 
amyloid beta. Brain slices from mouse and rabbit samples are washed with this 
solution and later imaged in a microscope to observe signs of lingering amyloid-beta.  
Materials and Methods
Results
Using the new double conjugation method, we were able to improve the conjugation efficiency of protein to MNS to 71.3%. This new probe was used in 
the rabbit model, and has been successful in preliminary tests. The presence of dark black spots in figure 5 (top of right image) above demonstrate the 
AβO-specific antibody binding to AβOs in the hippocampal region and the MNS bound to these antibodies giving off a strong signal in the MRI scan images. 
This signal did not significantly decrease after 48 hours, indicating long-term viability of the probe. In the future, we will work on testing the probe on a 
larger rabbit population to confirm our preliminary results, and begin to work on developing a probe for human use. The rabbit models proved to be more 
effective than the mice models, and the results from this series of experiments are more significant due to the rabbit’s 99.9 homology with humans for 
their AD gene. The mice’s successful tests provided a segway into the imaging of the rabbits, allowing us to realize that the probes effectively detected 
amyloid-beta oligomers. This diagnostic model has the potential to improve the efficiency of Alzheimer’s diagnostics, saving energy, people, and money on 
a global scale, as well as improve pharmaceuticals by determining the true impact these future drugs will have on onset. 
Conclusion & Discussion
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Absorbance of ACUMNS Solution
Original 
ACU193 Sample
After 1 
Conjugation 
Flow-Through
After 2 
Conjugation 
Flow-Throughs
Trial 1 0.111 0.110 1.863
Trial 2 0.107 0.107 1.869
Average 0.109 0.1085 1.866
Protein 
Concentration 
(mg/mL)
-0.054 -0.054 2.134
Figure 1 (left): This is the absorbance graph was made from the data 
provided by the BCA Assay of standard concentrations. The line of 
best fit from this data was used to determine the protein 
concentration of supernatant and ACUMNS samples in the double 
conjugation method.
Figure 2 (right): This table on the right demonstrates a source of 
error, due to an underestimation of our line of best fit, but still shows 
progression from the the original sample probes to the new probes, 
which has a conjugation efficiency of 71.3%. 
Figure 3 (left) & 4 (right): This is one of our early mouse MRI scans and depicts the presence of probe. 
The figure to the left is a wild type, thus we should see no presence of the probe, while the figure on 
the right is a transgenic mice model. The darker gray areas indicate the probe signaling.  
Figure 5: This is 
an example of 
an ex vivo rabbit 
image. The 
image on the 
left is control 
(pre-injection) 
and the right is 
post-injection. 
Dark spots in 
hippocampal 
region at the top 
on right indicate  
probe signaling.
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